rs12899226
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_000745.4(CHRNA5):c.*1843T>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.033 in 158,372 control chromosomes in the GnomAD database, including 125 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.032 ( 111 hom., cov: 32)
Exomes 𝑓: 0.058 ( 14 hom. )
Consequence
CHRNA5
NM_000745.4 3_prime_UTR
NM_000745.4 3_prime_UTR
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.504
Publications
8 publications found
Genes affected
CHRNA5 (HGNC:1959): (cholinergic receptor nicotinic alpha 5 subunit) The protein encoded by this gene is a nicotinic acetylcholine receptor subunit and a member of a superfamily of ligand-gated ion channels that mediate fast signal transmission at synapses. These receptors are thought to be heteropentamers composed of separate but similar subunits. Defects in this gene have been linked to susceptibility to lung cancer type 2 (LNCR2).[provided by RefSeq, Jun 2010]
CHRNA3 (HGNC:1957): (cholinergic receptor nicotinic alpha 3 subunit) This locus encodes a member of the nicotinic acetylcholine receptor family of proteins. Members of this family of proteins form pentameric complexes comprised of both alpha and beta subunits. This locus encodes an alpha-type subunit, as it contains characteristic adjacent cysteine residues. The encoded protein is a ligand-gated ion channel that likely plays a role in neurotransmission. Polymorphisms in this gene have been associated with an increased risk of smoking initiation and an increased susceptibility to lung cancer. Alternatively spliced transcript variants have been described. [provided by RefSeq, Nov 2009]
CHRNA3 Gene-Disease associations (from GenCC):
- urinary bladder, atony ofInheritance: AR Classification: STRONG Submitted by: Ambry Genetics, G2P
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BA1
GnomAdExome4 highest subpopulation (MID) allele frequency at 95% confidence interval = 0.0556 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0320 AC: 4865AN: 152142Hom.: 111 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
4865
AN:
152142
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0578 AC: 353AN: 6112Hom.: 14 Cov.: 4 AF XY: 0.0602 AC XY: 180AN XY: 2988 show subpopulations
GnomAD4 exome
AF:
AC:
353
AN:
6112
Hom.:
Cov.:
4
AF XY:
AC XY:
180
AN XY:
2988
show subpopulations
African (AFR)
AF:
AC:
0
AN:
94
American (AMR)
AF:
AC:
0
AN:
2
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
44
East Asian (EAS)
AF:
AC:
0
AN:
14
South Asian (SAS)
AF:
AC:
2
AN:
134
European-Finnish (FIN)
AF:
AC:
0
AN:
4
Middle Eastern (MID)
AF:
AC:
1
AN:
10
European-Non Finnish (NFE)
AF:
AC:
340
AN:
5582
Other (OTH)
AF:
AC:
10
AN:
228
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
15
31
46
62
77
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0320 AC: 4866AN: 152260Hom.: 111 Cov.: 32 AF XY: 0.0305 AC XY: 2272AN XY: 74434 show subpopulations
GnomAD4 genome
AF:
AC:
4866
AN:
152260
Hom.:
Cov.:
32
AF XY:
AC XY:
2272
AN XY:
74434
show subpopulations
African (AFR)
AF:
AC:
506
AN:
41548
American (AMR)
AF:
AC:
367
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
AC:
72
AN:
3466
East Asian (EAS)
AF:
AC:
45
AN:
5174
South Asian (SAS)
AF:
AC:
95
AN:
4822
European-Finnish (FIN)
AF:
AC:
277
AN:
10606
Middle Eastern (MID)
AF:
AC:
6
AN:
294
European-Non Finnish (NFE)
AF:
AC:
3427
AN:
68030
Other (OTH)
AF:
AC:
62
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
242
484
725
967
1209
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
60
120
180
240
300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
58
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.